Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.048
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Nature ; 631(8022): 826-834, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38987597

ABSTRACT

Glutamate is traditionally viewed as the first messenger to activate NMDAR (N-methyl-D-aspartate receptor)-dependent cell death pathways in stroke1,2, but unsuccessful clinical trials with NMDAR antagonists implicate the engagement of other mechanisms3-7. Here we show that glutamate and its structural analogues, including NMDAR antagonist L-AP5 (also known as APV), robustly potentiate currents mediated by acid-sensing ion channels (ASICs) associated with acidosis-induced neurotoxicity in stroke4. Glutamate increases the affinity of ASICs for protons and their open probability, aggravating ischaemic neurotoxicity in both in vitro and in vivo models. Site-directed mutagenesis, structure-based modelling and functional assays reveal a bona fide glutamate-binding cavity in the extracellular domain of ASIC1a. Computational drug screening identified a small molecule, LK-2, that binds to this cavity and abolishes glutamate-dependent potentiation of ASIC currents but spares NMDARs. LK-2 reduces the infarct volume and improves sensorimotor recovery in a mouse model of ischaemic stroke, reminiscent of that seen in mice with Asic1a knockout or knockout of other cation channels4-7. We conclude that glutamate functions as a positive allosteric modulator for ASICs to exacerbate neurotoxicity, and preferential targeting of the glutamate-binding site on ASICs over that on NMDARs may be strategized for developing stroke therapeutics lacking the psychotic side effects of NMDAR antagonists.


Subject(s)
Acid Sensing Ion Channels , Brain Ischemia , Glutamic Acid , Animals , Female , Humans , Male , Mice , 2-Amino-5-phosphonovalerate/adverse effects , 2-Amino-5-phosphonovalerate/metabolism , 2-Amino-5-phosphonovalerate/pharmacology , Acid Sensing Ion Channels/chemistry , Acid Sensing Ion Channels/deficiency , Acid Sensing Ion Channels/drug effects , Acid Sensing Ion Channels/genetics , Acid Sensing Ion Channels/metabolism , Allosteric Regulation/drug effects , Binding Sites/genetics , Brain Ischemia/chemically induced , Brain Ischemia/drug therapy , Brain Ischemia/metabolism , Brain Ischemia/pathology , Disease Models, Animal , Drug Evaluation, Preclinical , Glutamic Acid/analogs & derivatives , Glutamic Acid/metabolism , Glutamic Acid/pharmacology , Glutamic Acid/toxicity , Mice, Knockout , Mutagenesis, Site-Directed , Protons , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/chemistry , Receptors, N-Methyl-D-Aspartate/metabolism
2.
Behav Pharmacol ; 35(6): 327-337, 2024 Sep 01.
Article in English | MEDLINE | ID: mdl-39051912

ABSTRACT

Emerging evidence suggests that crocin rescues stress-induced depressive symptoms in mice via stimulation of hippocampal neurogenesis. Glutamate modulators mainly involving N-methyl- d -aspartate (NMDA) receptors (NMDARs) have highlighted a role in neural development, synaptic plasticity, and depression. The research presented here was designed to appraise the interaction between NMDAR agents and crocin on depressive-related behaviors in the NMRI male mice exposed to acute restraint stress (ARS) for a period of 4 h. The mice were submitted to the splash test, forced swimming test, and tail suspension test to evaluate depressive-like behavior. The ARS decreased the grooming duration in the splash test and increased immobility time in the forced swimming test and tail suspension test, suggesting a depressive-like phenotype. NMDA (0.25 and 0.5 µg/mouse, intracerebroventricular) did not alter depression-related profiles in both non-acute restraint stress (NARS) and ARS mice, while the same doses of NMDAR antagonist D-AP5 potentiated the antidepressive-like activities in the ARS mice compared with the NARS mice. Moreover, a low dose of NMDA did not change depression-related parameters in the crocin-treated NARS or ARS mice, while D-AP5 enhanced the crocin response in the NARS and ARS mice. Isobologram analysis noted a synergism between crocin and D-AP5 on antidepressive-like behavior in the NARS and ARS mice. Collectively, the combination of crocin and D-AP5 was shown to mitigate depression symptoms and can be potentially used for the treatment of depression disorders.


Subject(s)
Antidepressive Agents , Carotenoids , Depression , Drug Synergism , Restraint, Physical , Stress, Psychological , Animals , Male , Mice , Stress, Psychological/drug therapy , Stress, Psychological/metabolism , Depression/drug therapy , Antidepressive Agents/pharmacology , Carotenoids/pharmacology , 2-Amino-5-phosphonovalerate/pharmacology , Receptors, N-Methyl-D-Aspartate/metabolism , N-Methylaspartate/pharmacology , N-Methylaspartate/metabolism , Disease Models, Animal , Hindlimb Suspension , Behavior, Animal/drug effects , Swimming , Dose-Response Relationship, Drug
3.
Neurobiol Learn Mem ; 197: 107709, 2023 01.
Article in English | MEDLINE | ID: mdl-36503101

ABSTRACT

The present study investigated whether N-methyl-d-aspartate (NMDA) receptors in the dorsolateral striatum (DLS) mediate consolidation and retrieval of habit memory. Adult male Long-Evans rats were trained in a response learning version of a water plus-maze task in which rats were reinforced to make a habitual and consistent body-turn response at the maze choice point in order to mount a hidden escape platform. Prior research indicates that acquisition, consolidation, and retrieval in this task requires DLS function. The present study consisted of two experiments. In Experiment 1, rats received intra-DLS post-training injections of the NMDA receptor antagonist 2-amino-5- phosphonopentanoic acid (AP5; 2 µg/side) to examine the role of NMDA receptors in consolidation of habit memory. In Experiment 2, different groups of rats received a single pre-retrieval injection of AP5 in the DLS (AP5; 2 µg/side) during the last day of maze training to examine the potential role of NMDA receptors in retrieval of habit memory. Results indicated that post-training intra-DLS AP5 injections impaired memory consolidation. However, administration of AP5 at the same dose that impaired consolidation had no effect on memory retrieval. The findings are consistent with previous research indicating a role for NMDA receptors in the DLS in memory consolidation, and suggest that NMDA-dependent synaptic activity in the DLS may not be a critical component of habit memory retrieval.


Subject(s)
N-Methylaspartate , Receptors, N-Methyl-D-Aspartate , Rats , Male , Animals , Receptors, N-Methyl-D-Aspartate/physiology , Rats, Long-Evans , N-Methylaspartate/pharmacology , Memory/physiology , Habits , 2-Amino-5-phosphonovalerate/pharmacology
4.
J Neurosci ; 41(35): 7340-7349, 2021 09 01.
Article in English | MEDLINE | ID: mdl-34290083

ABSTRACT

Alzheimer's disease (AD) is a progressive neurodegenerative disease marked by the accumulation of amyloid-ß (Aß) plaques and neurofibrillary tangles. Aß oligomers cause synaptic dysfunction early in AD by enhancing long-term depression (LTD; a paradigm for forgetfulness) via metabotropic glutamate receptor (mGluR)-dependent regulation of striatal-enriched tyrosine phosphatase (STEP61). Reelin is a neuromodulator that signals through ApoE (apolipoprotein E) receptors to protect the synapse against Aß toxicity (Durakoglugil et al., 2009) Reelin signaling is impaired by ApoE4, the most important genetic risk factor for AD, and Aß-oligomers activate metabotropic glutamate receptors (Renner et al., 2010). We therefore asked whether Reelin might also affect mGluR-LTD. To this end, we induced chemical mGluR-LTD using DHPG (Dihydroxyphenylglycine), a selective mGluR5 agonist. We found that exogenous Reelin reduces the DHPG-induced increase in STEP61, prevents the dephosphorylation of GluA2, and concomitantly blocks mGluR-mediated LTD. By contrast, Reelin deficiency increased expression of Ca2+-permeable GluA2-lacking AMPA receptors along with higher STEP61 levels, resulting in occlusion of DHPG-induced LTD in hippocampal CA1 neurons. We propose a model in which Reelin modulates local protein synthesis as well as AMPA receptor subunit composition through modulation of mGluR-mediated signaling with implications for memory consolidation or neurodegeneration.SIGNIFICANCE STATEMENT Reelin is an important neuromodulator, which in the adult brain controls synaptic plasticity and protects against neurodegeneration. Amyloid-ß has been shown to use mGluRs to induce synaptic depression through endocytosis of NMDA and AMPA receptors, a mechanism referred to as LTD, a paradigm of forgetfulness. Our results show that Reelin regulates the phosphatase STEP, which plays an important role in neurodegeneration, as well as the expression of calcium-permeable AMPA receptors, which play a role in memory formation. These data suggest that Reelin uses mGluR LTD pathways to regulate memory formation as well as neurodegeneration.


Subject(s)
Long-Term Synaptic Depression/physiology , Neurons/physiology , Protein Tyrosine Phosphatases, Non-Receptor/physiology , Receptors, Metabotropic Glutamate/physiology , Reelin Protein/physiology , 2-Amino-5-phosphonovalerate/pharmacology , Animals , CA1 Region, Hippocampal/cytology , CA1 Region, Hippocampal/drug effects , Calcium/physiology , Cells, Cultured , Cerebral Cortex/cytology , Enzyme Induction/drug effects , Long-Term Synaptic Depression/drug effects , Memory/physiology , Methoxyhydroxyphenylglycol/analogs & derivatives , Methoxyhydroxyphenylglycol/pharmacology , Mice , Nerve Degeneration/physiopathology , Neurons/drug effects , Patch-Clamp Techniques , Phosphorylation/drug effects , Picrotoxin/pharmacology , Protein Processing, Post-Translational/drug effects , Rats , Rats, Sprague-Dawley , Receptors, AMPA/metabolism , Receptors, Metabotropic Glutamate/agonists , Recombinant Proteins/metabolism , Reelin Protein/deficiency , Reelin Protein/genetics
5.
Am J Physiol Heart Circ Physiol ; 321(3): H580-H591, 2021 09 01.
Article in English | MEDLINE | ID: mdl-34355986

ABSTRACT

Tumor necrosis factor-α (TNFα) in the hypothalamic paraventricular nucleus (PVN) contributes to increased sympathetic nerve activity (SNA) in cardiovascular disease models, but mechanisms are incompletely understood. As previously reported, bilateral PVN TNFα (0.6 pmol, 50 nL) induced acute ramping of splanchnic SNA (SSNA) that averaged +64 ± 7% after 60 min and +109 ± 17% after 120 min (P < 0.0001, n = 10). Given that TNFα can rapidly strengthen glutamatergic transmission, we hypothesized that progressive activation of ionotropic glutamate receptors is critically involved. When compared with that of vehicle (n = 5), prior blockade of PVN AMPA or NMDA receptors in anesthetized (urethane/α-chloralose) adult male Sprague-Dawley rats dose-dependently (ED50: 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX), 2.48 nmol; D-(-)-2-amino-5-phosphonopentanoic acid (APV), 12.33 nmol), but incompletely (Emax: NBQX, 64%; APV, 41%), attenuated TNFα-induced SSNA ramping (n = 5/dose). By contrast, combined receptor blockade prevented ramping (1.3 ± 2.1%, P < 0.0001, n = 5). Whereas separate blockade of PVN AMPA or NMDA receptors (n = 5/group) had little effect on continued SSNA ramping when performed 60 min after TNFα injection, combined blockade (n = 5) or PVN inhibition with the GABA-A receptor agonist muscimol (n = 5) effectively stalled, without reversing, the SSNA ramp. Notably, PVN TNFα increased local TNFα immunofluorescence after 120, but not 60 min. Findings indicate that AMPA and NMDA receptors each contribute to SSNA ramping to PVN TNFα, and that their collective availability and ongoing activity are required to initiate and sustain the ramping response. We conclude that acute sympathetic activation by PVN TNFα involves progressive local glutamatergic excitation that recruits downstream neurons capable of maintaining heightened SSNA, but incapable of sustaining SSNA ramping.NEW & NOTEWORTHY The proinflammatory cytokine TNFα contributes to heightened SNA in cardiovascular disease models, but mechanisms remain obscure. Here, we demonstrate that TNFα injection into the hypothalamic PVN triggers SNA ramping by mechanisms dependent on local ionotropic glutamate receptor availability, but largely independent of TNFα autoinduction. Continued SNA ramping depends on ionotropic glutamate receptor and neuronal activity in PVN, indicating that strengthening and/or increased efficacy of glutamatergic transmission is necessary for acute sympathoexcitation by PVN TNFα.


Subject(s)
Paraventricular Hypothalamic Nucleus/metabolism , Receptors, AMPA/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Splanchnic Nerves/metabolism , Tumor Necrosis Factor-alpha/metabolism , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Excitatory Amino Acid Antagonists/pharmacology , GABA-A Receptor Agonists/pharmacology , Male , Muscimol/pharmacology , Paraventricular Hypothalamic Nucleus/physiology , Quinoxalines/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/metabolism , Splanchnic Nerves/drug effects , Splanchnic Nerves/physiology
6.
J Neurosci ; 39(23): 4448-4460, 2019 06 05.
Article in English | MEDLINE | ID: mdl-30936241

ABSTRACT

Striatal output pathways are known to play a crucial role in the control of movement. One possible component for shaping the synaptic output of striatal neuron is the glutamatergic input that originates from cortex and thalamus. Although reports focusing on quantifying glutamatergic-induced morphological changes in striatum exist, the role of glutamatergic input in regulating striatal function remains poorly understood. Using primary neurons from newborn mice of either sex in a reduced two-neuron microcircuit culture system, we examined whether glutamatergic input modulates the output of striatal neurons. We found that glutamatergic input enhanced striatal inhibition in vitro With a glutamatergic partner from either cortex or thalamus, we attributed this potentiation to an increase in the size of quantal IPSC, suggesting a strengthening of the postsynaptic response to GABAergic signaling. Additionally, a differential effect of cortical and thalamic innervation onto striatal GABAergic neurons output was revealed. We observed that cortical, but not thalamic input, enhanced the number of releasable GABAergic synaptic vesicles and morphological synapses. Importantly, these alterations were reverted by blockade of neuronal activity and glutamate receptors, as well as disruption of BDNF-TrkB signaling. Together, our data indicate, for first time, that GABAergic synapse formation in corticostriatal pairs depends on two parallel, but potentially intersecting, signaling pathways that involve glutamate receptor activation in striatal neurons, as well as BDNF signaling. Understanding how cortical and thalamic inputs refine striatal output will pave the way toward dissecting basal ganglia activity in both physiological and pathological conditions.SIGNIFICANCE STATEMENT Striatal GABAergic microcircuits are critical for motor function. However, the mechanisms controlling striatal output, particularly at the level of synaptic strength, are unclear. Using two-neuron culture system, we quantified the synaptic output of individual striatal GABAergic neurons paired with a glutamatergic partner and studied the influence of the excitatory connections that are known to be interregionally formed in vivo We found that glutamatergic input potentiated striatal inhibitory output, potentially involving an increased feedback and/or feedforward inhibition. Moreover, distinct components of glutamatergic innervation, such as firing activity or release of neurotrophic factors were shown to be required for the glutamatergic-induced phenotype. Investigation, therefore, of two-neuron in vitro microcircuits could be a powerful tool to explore synaptic mechanisms or disease pathophysiology.


Subject(s)
Corpus Striatum/physiology , GABAergic Neurons/physiology , Glutamic Acid/physiology , Synapses/physiology , gamma-Aminobutyric Acid/physiology , 2-Amino-5-phosphonovalerate/pharmacology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Antibodies, Neutralizing/pharmacology , Brain-Derived Neurotrophic Factor/antagonists & inhibitors , Brain-Derived Neurotrophic Factor/pharmacology , Brain-Derived Neurotrophic Factor/physiology , Cells, Cultured , Cerebral Cortex/cytology , Corpus Striatum/drug effects , Excitatory Amino Acid Antagonists/pharmacology , Female , GABAergic Neurons/drug effects , Inhibitory Postsynaptic Potentials/drug effects , Inhibitory Postsynaptic Potentials/physiology , Male , Membrane Glycoproteins/physiology , Mice , Mice, Inbred C57BL , Miniature Postsynaptic Potentials/drug effects , Miniature Postsynaptic Potentials/physiology , Protein-Tyrosine Kinases/physiology , Quinoxalines/pharmacology , Recombinant Proteins/pharmacology , Synaptic Vesicles/physiology , Tetrodotoxin/pharmacology , Thalamus/cytology
7.
Glia ; 67(5): 915-934, 2019 05.
Article in English | MEDLINE | ID: mdl-30632636

ABSTRACT

Optogenetics has been widely expanded to enhance or suppress neuronal activity and it has been recently applied to glial cells. Here, we have used a new approach based on selective expression of melanopsin, a G-protein-coupled photopigment, in astrocytes to trigger Ca2+ signaling. Using the genetically encoded Ca2+ indicator GCaMP6f and two-photon imaging, we show that melanopsin is both competent to stimulate robust IP3-dependent Ca2+ signals in astrocyte fine processes, and to evoke an ATP/Adenosine-dependent transient boost of hippocampal excitatory synaptic transmission. Additionally, under low-frequency light stimulation conditions, melanopsin-transfected astrocytes can trigger long-term synaptic changes. In vivo, melanopsin-astrocyte activation enhances episodic-like memory, suggesting melanopsin as an optical tool that could recapitulate the wide range of regulatory actions of astrocytes on neuronal networks in behaving animals. These results describe a novel approach using melanopsin as a precise trigger for astrocytes that mimics their endogenous G-protein signaling pathways, and present melanopsin as a valuable optical tool for neuron-glia studies.


Subject(s)
Astrocytes/metabolism , Nerve Net/metabolism , Neurons/metabolism , Optogenetics/methods , Rod Opsins/metabolism , 2-Amino-5-phosphonovalerate/pharmacology , Adenosine A2 Receptor Antagonists/pharmacology , Alanine/analogs & derivatives , Alanine/pharmacology , Animals , Azo Compounds/pharmacology , Channelrhodopsins/genetics , Channelrhodopsins/metabolism , Chelating Agents/pharmacology , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Glial Fibrillary Acidic Protein/genetics , Glial Fibrillary Acidic Protein/metabolism , Hippocampus/cytology , Inositol 1,4,5-Trisphosphate Receptors/genetics , Inositol 1,4,5-Trisphosphate Receptors/metabolism , Light , Mice , Mice, Inbred C57BL , Mice, Transgenic , Pyridoxal Phosphate/analogs & derivatives , Pyridoxal Phosphate/pharmacology , Pyrimidines/pharmacology , Rod Opsins/genetics , Synaptic Potentials/physiology , Triazoles/pharmacology , Xanthenes/pharmacology
8.
Mol Pain ; 15: 1744806919832718, 2019.
Article in English | MEDLINE | ID: mdl-30717631

ABSTRACT

The neuropeptide of calcitonin gene-related peptide (CGRP) plays critical roles in chronic pain, especially in migraine. Immunohistochemistry and in situ hybridization studies have shown that CGRP and its receptors are expressed in cortical areas including pain perception-related prefrontal anterior cingulate cortex. However, less information is available for the functional roles of CGRP in cortical regions such as the anterior cingulate cortex (ACC). Recent studies have consistently demonstrated that long-term potentiation is a key cellular mechanism for chronic pain in the ACC. In the present study, we used 64-electrode array field recording system to investigate the effect of CGRP on excitatory transmission in the ACC. We found that CGRP induced potentiation of synaptic transmission in a dose-dependently manner (1, 10, 50, and 100 nM). CGRP also recruited inactive circuit in the ACC. An application of the calcitonin receptor-like receptor antagonist CGRP8-37 blocked CGRP-induced chemical long-term potentiation and the recruitment of inactive channels. CGRP-induced long-term potentiation was also blocked by N-methyl-D-aspartate (NMDA) receptor antagonist AP-5. Consistently, the application of CGRP increased NMDA receptor-mediated excitatory postsynaptic currents. Finally, we found that CGRP-induced long-term potentiation required the activation of calcium-stimulated adenylyl cyclase subtype 1 (AC1) and protein kinase A. Genetic deletion of AC1 using AC1-/- mice, an AC1 inhibitor NB001 or a protein kinase A inhibitor KT5720, all reduced or blocked CGRP-induced potentiation. Our results provide direct evidence that CGRP may contribute to synaptic potentiation in important physiological and pathological conditions in the ACC, an AC1 inhibitor NB001 may be beneficial for the treatment of chronic headache.


Subject(s)
Calcitonin Gene-Related Peptide/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Gyrus Cinguli/drug effects , Nerve Net/drug effects , 2-Amino-5-phosphonovalerate/pharmacology , Adenylyl Cyclases/deficiency , Adenylyl Cyclases/genetics , Animals , Calcitonin Gene-Related Peptide/metabolism , Carbazoles/pharmacology , Electric Stimulation , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Gyrus Cinguli/metabolism , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Patch-Clamp Techniques , Pyrroles/pharmacology , Receptors, Calcitonin Gene-Related Peptide/metabolism , Signal Transduction/drug effects
9.
Eur J Neurosci ; 50(9): 3454-3471, 2019 11.
Article in English | MEDLINE | ID: mdl-31206829

ABSTRACT

The activation of N-methyl-D-aspartate receptors (NMDARs) in substantia nigra pars compacta (SNc) dopamine (DA) cells is central to generate the bursting activity, a phasic signal linked to DA-related behaviours via the change in postsynaptic DA release. NMDARs are recruited during excitatory synaptic transmission by glutamate release, but the glycine site level of occupancy of these receptors during basal action potential-dependent activity is not known for SNc DA neurons. We explored NMDAR-dependent signals during exogenous applications of co-agonists in midbrain slices from juvenile rats. We found that both glycine and D-serine strengthened the NMDAR-dependent component of excitatory postsynaptic currents (EPSCs) in a concentration-dependent manner. EPSCs were also increased by endogenous glycine via the blockade of the glycine transport. The glycine site of NMDARs contributing to synaptic transmission is therefore subsaturated. The behaviourally relevant burst firing was more sensitive to exogenous D-serine and endogenous glycine than to exogenous glycine. The mechanisms regulating the availability of the co-agonists exert consequently a critical influence on the excitability of DA neurons via NMDARs. The modulation of the phasic firing in DA neurons by ambient NMDAR co-agonists may be important for nigral information processing and downstream motor-related behaviour.


Subject(s)
Dopaminergic Neurons/physiology , Excitatory Postsynaptic Potentials/physiology , Pars Compacta/physiology , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Dose-Response Relationship, Drug , Excitatory Amino Acid Agonists/pharmacology , Glycine/pharmacology , Kynurenic Acid/analogs & derivatives , Kynurenic Acid/pharmacology , Phosphinic Acids/pharmacology , Propanolamines/pharmacology , Rats , Receptors, N-Methyl-D-Aspartate/metabolism , Serine/pharmacology
10.
Eur J Neurosci ; 50(9): 3403-3415, 2019 11.
Article in English | MEDLINE | ID: mdl-31340074

ABSTRACT

Nucleus accumbens dopamine plays a key role in reward-directed approach. Past findings suggest that dopamine's role in the expression of learned behavior diminishes with extended training. However, little is known about the central substrates that mediate the shift to dopamine-independent reward approach. In the present study, rats approached and inserted the head into a reward compartment in response to a cue signaling food delivery. On days 4 and 5 of 28-trial-per-day sessions, D1 receptor antagonist R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) infused to the NAc core reduced the probability and speed of cued approach. The disruptive effect of D1 receptor blockade was specific to the nucleus accumbens core and not seen with drug infusions to nearby dopamine target regions. In rats that received drug infusions after extended training (days 10 or 11), accumbens core D1 receptor blockade produced little effect on the expression of the same behavior. These results could have been due to a continued accumbens mediation of cued approach even after the behavior had become independent of accumbens D1 receptors. However, accumbens core ionotropic glutamate receptor blockade disrupted cued approach during early but not late stages of training, similar to the effects of D1 antagonist infusions. The results suggest that with extended training, a nucleus accumbens D1-dependent behavior becomes less dependent not only on nucleus accumbens D1 transmission but also on excitatory transmission in the nucleus accumbens. These findings fill an important gap in a growing literature on reorganization of striatal function over the course of training.


Subject(s)
Choice Behavior/physiology , Dopamine/physiology , Learning/physiology , Nucleus Accumbens/physiology , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , 2-Amino-5-phosphonovalerate/administration & dosage , 2-Amino-5-phosphonovalerate/pharmacology , 6-Cyano-7-nitroquinoxaline-2,3-dione/administration & dosage , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Animals , Benzazepines/administration & dosage , Benzazepines/pharmacology , Choice Behavior/drug effects , Dopamine/metabolism , Learning/drug effects , Male , Microinjections , Nucleus Accumbens/drug effects , Quinpirole/pharmacology , Rats , Reward , Time Factors
11.
Behav Pharmacol ; 30(1): 59-66, 2019 02.
Article in English | MEDLINE | ID: mdl-30299277

ABSTRACT

The transient receptor potential vanilloid 1 (TRPV1) can modulate stress-related behaviours, thus representing an interesting target for new antidepressant drugs. TRPV1 can trigger glutamate release and nitric oxide synthesis in the brain, mechanisms also involved in the neurobiology of depression. However, it is not known if these mechanisms are involved in TRPV1-induced behavioural effects. Therefore, the aim of this study was to verify if the antidepressant-like effect induced by a TRPV1 antagonist in mice submitted to the forced swimming test (FST) would be facilitated by combined treatment with neuronal nitric oxide synthase (nNOS) inhibition and N-methyl-D-aspartate (NMDA) blockade. Male Swiss mice were given (intracerebroventricular) injections of capsazepine (CPZ) (TRPV1 antagonist - 0.05/0.1/0.3/0.6 nmol/µl), and AP7 (NMDA antagonist - 1/3/10 nmol/µl) or N-propyl-L-arginine (NPA, nNOS inhibitor - 0.001/0.01/0.1 nmol/µl), and 10 min later, submitted to an open field test, and immediately afterwards, to the FST. An additional group received coadministration of CPZ and AP7 or CPZ and NPA, in subeffective doses. The results demonstrated that CPZ (0.1 nmol/µl), AP7 (3 nmol/µl) and NPA (0.01/0.1 nmol/µl) induced antidepressant-like effects. Moreover, coadministration of subeffective doses of CPZ and AP7 or CPZ and NPA induced significant antidepressant-like effects. Altogether, the data indicate that blockade of TRPV1 receptors by CPZ induces antidepressant-like effects and that both nNOS inhibition and NMDA blockade facilitate CPZ effects in the FST.


Subject(s)
Antidepressive Agents/therapeutic use , Capsaicin/analogs & derivatives , Depression/drug therapy , Glutamic Acid/metabolism , Nitric Oxide/metabolism , Swimming/psychology , 2-Amino-5-phosphonovalerate/analogs & derivatives , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Apomorphine/analogs & derivatives , Apomorphine/pharmacology , Arginine/pharmacology , Capsaicin/therapeutic use , Cyclic GMP/metabolism , Depression/metabolism , Depression/physiopathology , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Administration Routes , Enzyme Inhibitors/pharmacology , Exploratory Behavior/drug effects , Male , Microinjections , Nitroprusside/metabolism , Rats , Receptors, N-Methyl-D-Aspartate/metabolism , Statistics, Nonparametric
12.
Exp Cell Res ; 371(2): 389-398, 2018 10 15.
Article in English | MEDLINE | ID: mdl-30176218

ABSTRACT

Neurons are highly polarized cells with an axon and dendritic arbors. It is still not well studied that how formation and elaboration of axon and dendrites is controlled by diffusible signaling factors such as glutamate via specific receptors. We found that N-methyl-D-aspartate (NMDA) receptors were enriched (stage 2-3) but decreased expression (stage 4-5) at tip of axon of cultured hippocampal neurons during distinct development stages. Inhibition of NMDA receptor activity by competitive antagonist DL-2-amino-5-phosphonovalerate (APV) or channel blocker MK801 promoted axonal outgrowth at the early stages, whereas inhibited dendritic development in later stages. Meanwhile, knockdown of NMDA receptors also promoted axonal outgrowth and branch in immature neurons. Furthermore, GluN2B but not GluN2A subunit inhibited axonal outgrowth in immature hippocampal neurons. Finally, we found that NMDA receptors inhibited axonal outgrowth by inactivating Akt and activating GSK-3ß signaling in a calcineurin-dependent manner. Taken together, our results demonstrate that stabilization GSK-3ß activation in the axon growth cone by Ca2+ influx through NMDA receptors may be involved in regulation of axon formation in immature neurons at early stages.


Subject(s)
Calcineurin/genetics , Glycogen Synthase Kinase 3 beta/genetics , Neuronal Plasticity/genetics , Neurons/metabolism , Proto-Oncogene Proteins c-akt/genetics , Receptors, N-Methyl-D-Aspartate/genetics , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Calcineurin/metabolism , Calcium/metabolism , Cations, Divalent , Dizocilpine Maleate/pharmacology , Embryo, Mammalian , Gene Expression Regulation, Developmental , Glycogen Synthase Kinase 3 beta/metabolism , Hippocampus/drug effects , Hippocampus/embryology , Hippocampus/metabolism , Ion Transport , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Neuronal Plasticity/drug effects , Neurons/cytology , Neurons/drug effects , Primary Cell Culture , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/metabolism , Signal Transduction
13.
Cereb Cortex ; 28(4): 1183-1194, 2018 04 01.
Article in English | MEDLINE | ID: mdl-28184425

ABSTRACT

The formation, plasticity and maintenance of synaptic connections is regulated by molecular and electrical signals. ß-Catenin is an important protein in these events and regulates cadherin-mediated cell adhesion and the recruitment of pre- and postsynaptic proteins in an activity-dependent fashion. Mutations in the ß-catenin gene can cause cognitive disability and autism, with life-long consequences. Understanding its synaptic function may thus be relevant for the treatment of these disorders. So far, ß-catenin's function has been studied predominantly in cell culture and during development but knowledge on its function in adulthood is limited. Here, we show that ablating ß-catenin in excitatory neurons of the adult visual cortex does not cause the same synaptic deficits previously observed during development. Instead, it reduces NMDA-receptor currents and impairs visual processing. We conclude that ß-catenin remains important for adult cortical function but through different mechanisms than during development.


Subject(s)
Receptors, N-Methyl-D-Aspartate/metabolism , Visual Cortex/metabolism , beta Catenin/metabolism , 2-Amino-5-phosphonovalerate/analogs & derivatives , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Electric Stimulation , Excitatory Amino Acid Antagonists/pharmacology , Gene Expression Regulation/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , N-Methylaspartate/metabolism , Parvalbumins/metabolism , Patch-Clamp Techniques , RNA, Messenger/metabolism , Sensory Deprivation , Synaptic Potentials/drug effects , Synaptic Potentials/genetics , Visual Cortex/drug effects , White Matter/drug effects , White Matter/physiology , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism , beta Catenin/genetics
14.
Cereb Cortex ; 28(5): 1568-1581, 2018 05 01.
Article in English | MEDLINE | ID: mdl-28334325

ABSTRACT

Brain-derived neurotrophic factor (BDNF) plays a critical role in modulating plasticity in sensory cortices. Indeed, a BDNF-dependent long-term potentiation (LTP) at distal basal excitatory synapses of Layer 5 pyramidal neurons (L5PNs) has been demonstrated in disinhibited rat barrel cortex slices. Although it is well established that this LTP requires the pairing of excitatory postsynaptic potentials (PSPs) with Ca2+ spikes, its induction when synaptic inhibition is working remains unexplored. Here we show that low-frequency stimulation at basal dendrites of L5PNs is able to trigger a PSP followed by an action potential (AP) and a slow depolarization (termed PSP-Ca2+ response) in thalamocortical slices without blocking synaptic inhibition. We demonstrate that AP barrage-mediated release of endocannabinoids (eCBs) from the recorded L5PNs induces PSP-Ca2+ response facilitation and BDNF-dependent LTP. Indeed, this LTP requires the type 1 cannabinoid receptors activation, is prevented by postsynaptic intracellular 1,2-bis(2-aminophenoxy) ethane-N,N,N,N'-tetraacetic acid (BAPTA) or the anandamide membrane transporter inhibitor AM404, and only occurs in L5PNs neurons showing depolarization-induced suppression of inhibition. Additionally, electrical stimulation at the posteromedial thalamic nucleus induced similar response and LTP. These results reveal a novel form of eCB-dependent LTP at L5PNs that could be relevant in the processing of sensory information in the barrel cortex.


Subject(s)
Cerebral Cortex/cytology , Endocannabinoids/metabolism , Long-Term Potentiation/physiology , Pyramidal Cells/physiology , Synaptic Transmission/physiology , 2-Amino-5-phosphonovalerate/pharmacology , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Animals , Animals, Newborn , Arachidonic Acids/pharmacology , Benzoxazines/pharmacology , Calcium Channel Blockers/pharmacology , Cerebral Cortex/physiology , Excitatory Amino Acid Antagonists/pharmacology , Extracellular Fluid/drug effects , Extracellular Fluid/metabolism , Long-Term Potentiation/drug effects , Morpholines/pharmacology , Naphthalenes/pharmacology , Neural Pathways/drug effects , Neural Pathways/physiology , Peptides, Cyclic/pharmacology , Pyramidal Cells/drug effects , Rats , Rats, Sprague-Dawley , Receptor, trkB/antagonists & inhibitors , Synaptic Transmission/drug effects , Thalamus/cytology
15.
Eur J Neurosci ; 47(7): 858-865, 2018 04.
Article in English | MEDLINE | ID: mdl-29405453

ABSTRACT

In sensory systems, the neuronal representation of external stimuli is enhanced along the sensory pathway. In the auditory system, strong enhancement of binaural information takes place between the brainstem and the midbrain; however, the underlying cellular mechanisms are unknown. Here we investigated the transformation of binaural information in the dorsal nucleus of the lateral lemniscus (DNLL), a nucleus that connects the binaural nuclei in the brainstem and the inferior colliculus in the midbrain. We used in vitro and in vivo electrophysiology in adult Mongolian gerbils to show that N-methyl-D-aspartate receptor (NMDARs) play a critical role in neuronal encoding of stimulus properties in the DNLL. While NMDARs increase firing rates, the timing and the accuracy of the neuronal responses remain unchanged. NMDAR-mediated excitation increases the information about the acoustic stimulus. Taken together, our results show that NMDARs in the DNLL enhance the auditory information content in adult mammal brainstem.


Subject(s)
Brain Stem/physiology , Receptors, N-Methyl-D-Aspartate/physiology , 2-Amino-5-phosphonovalerate/analogs & derivatives , 2-Amino-5-phosphonovalerate/pharmacology , Acoustic Stimulation , Action Potentials/physiology , Animals , Auditory Pathways/physiology , Female , Gerbillinae , Male , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors
16.
J Neurosci Res ; 96(7): 1324-1335, 2018 07.
Article in English | MEDLINE | ID: mdl-29577359

ABSTRACT

N-methyl-D-aspartate receptors (NMDARs) are ion channels comprising tetrameric assemblies of GluN1 and GluN2 receptor subunits that mediate excitatory neurotransmission in the central nervous system. Of the four different GluN2 subunits, the GluN2D subunit-containing NMDARs have been suggested as a target for antiparkinsonian therapy because of their expression pattern in some of the basal ganglia nuclei that show abnormal firing patterns in the parkinsonian state, specifically the subthalamic nucleus (STN). In this study, we demonstrate that blockade of NMDARs altered spike firing in the STN in a male nonhuman primate that had been rendered parkinsonian by treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. In accompanying experiments in male rodents, we found that GluN2D-NMDAR expression in the STN was reduced in acutely or chronically dopamine-depleted animals. Taken together, our data suggest that blockade of NMDARs in the STN may be a viable antiparkinsonian strategy, but that the ultimate success of this approach may be complicated by parkinsonism-associated changes in NMDAR expression in the STN.


Subject(s)
2-Amino-5-phosphonovalerate/pharmacology , Parkinsonian Disorders/enzymology , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Subthalamic Nucleus/enzymology , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , Action Potentials/physiology , Animals , Cattle , Excitatory Amino Acid Antagonists/pharmacology , MPTP Poisoning , Macaca mulatta , Male , Mice , Mice, Inbred C57BL , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Subthalamic Nucleus/drug effects , Subthalamic Nucleus/pathology , Synaptic Transmission/physiology
17.
Nature ; 486(7402): 251-5, 2012 May 20.
Article in English | MEDLINE | ID: mdl-22699618

ABSTRACT

We learn complex skills such as speech and dance through a gradual process of trial and error. Cortical-basal ganglia circuits have an important yet unresolved function in this trial-and-error skill learning; influential 'actor-critic' models propose that basal ganglia circuits generate a variety of behaviours during training and learn to implement the successful behaviours in their repertoire. Here we show that the anterior forebrain pathway (AFP), a cortical-basal ganglia circuit, contributes to skill learning even when it does not contribute to such 'exploratory' variation in behavioural performance during training. Blocking the output of the AFP while training Bengalese finches to modify their songs prevented the gradual improvement that normally occurs in this complex skill during training. However, unblocking the output of the AFP after training caused an immediate transition from naive performance to excellent performance, indicating that the AFP covertly gained the ability to implement learned skill performance without contributing to skill practice. In contrast, inactivating the output nucleus of the AFP during training completely prevented learning, indicating that learning requires activity within the AFP during training. Our results suggest a revised model of skill learning: basal ganglia circuits can monitor the consequences of behavioural variation produced by other brain regions and then direct those brain regions to implement more successful behaviours. The ability of the AFP to identify successful performances generated by other brain regions indicates that basal ganglia circuits receive a detailed efference copy of premotor activity in those regions. The capacity of the AFP to implement successful performances that were initially produced by other brain regions indicates precise functional connections between basal ganglia circuits and the motor regions that directly control performance.


Subject(s)
Basal Ganglia/physiology , Finches/physiology , Learning/physiology , Vocalization, Animal/physiology , 2-Amino-5-phosphonovalerate/pharmacology , Animals , Basal Ganglia/drug effects , Excitatory Amino Acid Antagonists/pharmacology , Finches/anatomy & histology , Learning/drug effects , Male , Prosencephalon/physiology , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Vocalization, Animal/drug effects
18.
Cereb Cortex ; 27(6): 3272-3283, 2017 06 01.
Article in English | MEDLINE | ID: mdl-28369311

ABSTRACT

Glutamate and K+, both released during neuronal firing, need to be tightly regulated to ensure accurate synaptic transmission. Extracellular glutamate and K+ ([K+]o) are rapidly taken up by glutamate transporters and K+-transporters or channels, respectively. Glutamate transport includes the exchange of one glutamate, 3 Na+, and one proton, in exchange for one K+. This K+ efflux allows the glutamate binding site to reorient in the outwardly facing position and start a new transport cycle. Here, we demonstrate the sensitivity of the transport process to [K+]o changes. Increasing [K+]o over the physiological range had an immediate and reversible inhibitory action on glutamate transporters. This K+-dependent transporter inhibition was revealed using microspectrofluorimetry in primary astrocytes, and whole-cell patch-clamp in acute brain slices and HEK293 cells expressing glutamate transporters. Previous studies demonstrated that pharmacological inhibition of glutamate transporters decreases neuronal transmission via extrasynaptic glutamate spillover and subsequent activation of metabotropic glutamate receptors (mGluRs). Here, we demonstrate that increasing [K+]o also causes a decrease in neuronal mEPSC frequency, which is prevented by group II mGluR inhibition. These findings highlight a novel, previously unreported physiological negative feedback mechanism in which [K+]o elevations inhibit glutamate transporters, unveiling a new mechanism for activity-dependent modulation of synaptic activity.


Subject(s)
Amino Acid Transport System X-AG/metabolism , Extracellular Fluid/metabolism , Neurons/physiology , Potassium/metabolism , Synaptic Transmission/physiology , 2-Amino-5-phosphonovalerate/pharmacology , Amino Acid Transport System X-AG/genetics , Amino Acids/pharmacology , Animals , Animals, Newborn , Aspartic Acid/analogs & derivatives , Aspartic Acid/pharmacology , Aspartic Acid/poisoning , Astrocytes/cytology , Astrocytes/drug effects , Astrocytes/physiology , Cerebral Cortex/cytology , Excitatory Amino Acid Antagonists/pharmacology , GABA-A Receptor Antagonists/pharmacology , Glutamic Acid/pharmacology , HEK293 Cells , Humans , Membrane Potentials/drug effects , Mice , Mice, Inbred C57BL , Neural Inhibition/drug effects , Neurons/drug effects , Potassium/pharmacology , Synaptic Transmission/drug effects , Xanthenes/pharmacology
19.
J Neurosci ; 36(23): 6165-74, 2016 06 08.
Article in English | MEDLINE | ID: mdl-27277795

ABSTRACT

UNLABELLED: Cortical spreading depression (CSD) is a propagating event of neuronal depolarization, which is considered as the cellular correlate of the migraine aura. It is characterized by a change in the intrinsic optical signal and by a negative DC potential shift. Microglia are the resident macrophages of the CNS and act as sensors for pathological changes. In the present study, we analyzed whether microglial cells might sense CSD by recording membrane currents from microglia in acutely isolated cortical mouse brain slices during an experimentally induced CSD. Coincident with the change in the intrinsic optical signal and the negative DC potential shift we recorded an increase in potassium conductance predominantly mediated by K(+) inward rectifier (Kir)2.1, which was blocked by the NMDA receptor antagonist D-AP5. Application of NMDA and an increase in extracellular K(+) mimics the CSD-induced Kir activation. Application of D-AP5, but not the purinergic receptor antagonist RB2, blocks the NMDA-induced Kir activation. The K(+) channel blocker Ba(2+) blocks both the CSD- and the NMDA-triggered increase in Kir channel activity. In addition, we could confirm previous findings that microglia in the adult brain do not express functional NMDA receptors by recording from microglia cultured from adult brain. From these observations we conclude that CSD activates neuronal NMDA receptors, which lead to an increase in extracellular [K(+)] resulting in the activation of Kir channel activity in microglia. SIGNIFICANCE STATEMENT: Cortical spreading depression (CSD) is a wave of neuronal depolarization spreading through the cortex and is associated with the aura of migraine. Here we show that microglial cells, which are viewed as pathologic sensors of the brain, can sense this wave. The increase in the extracellular potassium concentration associated with that wave leads to the activation of an inward rectifying potassium conductance in microglia. The involvement of neuronal NMDA receptors is crucial because NMDA mimics that response and microglia do not express functional NMDA receptors. Although it is now evident that CSD leads to a signal in microglia, the consequences of this microglial activation during CSD needs to be explored.


Subject(s)
Cortical Spreading Depression/physiology , Microglia/physiology , Potassium Channels, Inwardly Rectifying/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , 2-Amino-5-phosphonovalerate/pharmacology , Age Factors , Animals , Animals, Newborn , Barium/pharmacology , Cells, Cultured , Cortical Spreading Depression/drug effects , Enzyme Inhibitors/pharmacology , Female , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic , N-Methylaspartate/pharmacology , Potassium/metabolism , Potassium/pharmacology , Potassium Channel Blockers/pharmacology , Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/metabolism
20.
J Neurosci ; 36(11): 3336-49, 2016 Mar 16.
Article in English | MEDLINE | ID: mdl-26985041

ABSTRACT

Neurons that signal the orientation of edges within the visual field have been widely studied in primary visual cortex. Much less is known about the mechanisms of orientation selectivity that arise earlier in the visual stream. Here we examine the synaptic and morphological properties of a subtype of orientation-selective ganglion cell in the rabbit retina. The receptive field has an excitatory ON center, flanked by excitatory OFF regions, a structure similar to simple cell receptive fields in primary visual cortex. Examination of the light-evoked postsynaptic currents in these ON-type orientation-selective ganglion cells (ON-OSGCs) reveals that synaptic input is mediated almost exclusively through the ON pathway. Orientation selectivity is generated by larger excitation for preferred relative to orthogonal stimuli, and conversely larger inhibition for orthogonal relative to preferred stimuli. Excitatory orientation selectivity arises in part from the morphology of the dendritic arbors. Blocking GABAA receptors reduces orientation selectivity of the inhibitory synaptic inputs and the spiking responses. Negative contrast stimuli in the flanking regions produce orientation-selective excitation in part by disinhibition of a tonic NMDA receptor-mediated input arising from ON bipolar cells. Comparison with earlier studies of OFF-type OSGCs indicates that diverse synaptic circuits have evolved in the retina to detect the orientation of edges in the visual input. SIGNIFICANCE STATEMENT: A core goal for visual neuroscientists is to understand how neural circuits at each stage of the visual system extract and encode features from the visual scene. This study documents a novel type of orientation-selective ganglion cell in the retina and shows that the receptive field structure is remarkably similar to that of simple cells in primary visual cortex. However, the data indicate that, unlike in the cortex, orientation selectivity in the retina depends on the activity of inhibitory interneurons. The results further reveal the physiological basis for feature detection in the visual system, elucidate the synaptic mechanisms that generate orientation selectivity at an early stage of visual processing, and illustrate a novel role for NMDA receptors in retinal processing.


Subject(s)
Orientation/physiology , Retina/cytology , Retina/physiology , Retinal Ganglion Cells/physiology , Synapses/physiology , Visual Pathways/physiology , 2-Amino-5-phosphonovalerate/pharmacology , Action Potentials/physiology , Animals , Choline O-Acetyltransferase/metabolism , Dendrites/drug effects , Dendrites/physiology , Electric Stimulation , Excitatory Amino Acid Agents/pharmacology , Female , GABA Agents/pharmacology , In Vitro Techniques , Male , N-Methylaspartate/pharmacology , Patch-Clamp Techniques , Photic Stimulation , Rabbits , Retinal Ganglion Cells/cytology , Synapses/drug effects , Visual Pathways/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL